Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

1979 • 568 citations

Statistische Auswertungsmethoden.

1970 • 197 citations

Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

1979 • 189 citations

Fluorometric determination of acrolein and related compounds with m-aminophenol

1968 • 124 citations

Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metabolite

1975 • 124 citations

The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorines

1977 • 108 citations

Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.

1977 • 90 citations

Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.

1973 • 79 citations

Advances in Cancer Chemotherapy

1980 • 71 citations

Sachs, L.: Statistische Auswertungsmethoden. 2., neubearb. Aufl. Springer–Verlag, Berlin–Heidelberg–New York 1972. VIII, 105 S., 5 Abb., 25 Tab., 1 Klapptafel, DM 8,80

1974 • 71 citations

Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.

1976 • 70 citations

The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.

1976 • 62 citations

Studies on the human pharmacokinetics of isophosphamide (NSC-109724).

1976 • 52 citations

Studies on the metabolism of isopnosphamide (NSC-109724) in man.

1976 • 50 citations

Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.

1976 • 36 citations

Characterization and quantitative estimation of activated cyclophosphamide in blood and urine.

1977 • 36 citations

Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.

1976 • 35 citations

�ber Blutspiegel und Urin-Ausscheidung von aktiviertem Cyclophosphamid und seinen Deaktivierungsprodukten beim Menschen

1980 • 35 citations

Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.

1976 • 32 citations

Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).

1976 • 32 citations

[Studies on the spontaneous decomposition of 4-hydroxyphosphamide and 4-hydroperoxyphosphamide by means of thin-layer chromatography].

1974 • 22 citations

Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.

1976 • 19 citations

Fluorometrische Bestimmung von ?aktiviertem? Cyclophosphamid und Ifosfamid im Blut

1979 • 19 citations

Mass spectrometric characterization of activatedN-(2-chloroethyl)amido oxazaphosphorine derivatives

1977 • 16 citations

Species differences in the metabolism of p chloroamphetamine and its ability to lower cerebral serotonin

1969 • 16 citations

[Isolation and characterisation of two main metabolites of ifosfamide from human urine (author's transl)].

1976 • 7 citations